Tag: Heart Failure
Statement Addresses Concerns About Heart Meds and COVID-19
Patients advised to continue ACE inhibitors/ARBs after researcher posits risk for severe COVID-19 infection
Wearable Sensor Data Predict Heart Failure Rehospitalization
Machine learning algorithm detects worsening heart failure and predicts impending rehospitalization
Meta-Analyses Link Rosiglitazone to Increased Cardiovascular Risk
Authors call for sharing of individual patient data to strengthen meta-analyses focused on safety
LV Hypertrophy May Explain Racial Disparities in Heart Failure
Some of the excess risk for heart failure explained by higher prevalence of malignant LVH in blacks
Model Shows Transitional Care Cost-Effective in Heart Failure
All three transitional care interventions more costly and effective than standard care
Postdischarge Mortality Up for Patients With Heart Failure
Of conditions targeted by Hospital Readmissions Reduction Program, only heart failure mortality increased
Coronary Artery Disease Risk Down in Survivors of Childhood Cancer
Risk for coronary artery disease significantly decreased for survivors with diagnosis in 80s, 90s versus 70s
Outcomes Superior for HM3 LVAD Regardless of Preimplant Strategy
HeartMate 3 superior to HeartMate II whether device is bridge to transplant or destination therapy
Major Cardiovascular Diseases May Up Long-Term Risk for ESKD
Risk highest for heart failure; risk for heart failure nominally higher with preserved ejection fraction
Diabetes Mellitus May Increase Risk for Developing Heart Failure
Increased risk for heart failure also seen in group of participants without diastolic dysfunction